Nazar I. Herasymiuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nazar I. Herasymiuk has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Sviatoslav Ya. Kostiv
Department of Surgery No 2, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
2 shared publications - Boryslav P. Selskyi
Horbachevsky Ternopil National Medical University Ternopil Ukraine
1 shared publication Dariya Popovych
1 shared publicationI. K. Venher
1 shared publication- Ihor I. Loyko
Horbachevsky Ternopil National Medical University Ternopil Ukraine
1 shared publication - Ihor K. Venher
I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE
1 shared publication
Latest Publications
- Open Access
- 30 May 2025
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 5,p. 6-12
DIAGNOSIS OF POST COVID-19 DISORDERS IN THE FUNCTION OF THE ENDOTHELIUM
Introduction. One of the characteristics of COVID-19, caused by the SARS-CoV-2 virus, is the broad, nonspecific nature of the pathological processes that develop in almost all organs and organ systems of the human body. At the same time, the development of endothelial dysfunction has been identified by many investigators as the pathological process that integrates these disorders and is considered the primary pathophysiological mechanism in severe cases. Aim. Post-COVID-19 infection survivors in 2021–2022 (n = 502) underwent a Flow-Mediated Dilation (FMD) test of upper arm occlusion by the brachial artery. Materials and methods. In the non-invasive study, endothelial dysfunction (ED) was induced with a pneumatic cuff, thereby inflicting compression only on the distal circulation with reactive hyperemia. Manifestation of ED was evaluated by the diameter of the brachial artery (BA) being less than 10% compared to the baseline, or vasoconstriction. Results. The patients were divided into four groups by the severity of the disease. Group I (n = 262) comprised home-quarantined patients with mild symptoms (HQM); Group II (n = 183), patients hospitalized with moderate symptoms (HMO); Group III (n = 41), patients hospitalized with severe symptoms who required oxygen therapy (HSV); and Group IV (n = 16), patients in the Intensive Care Unit (ICU) hospitalized with critical symptoms (HCR). In HCR (Group IV), the reaction of the BA diameter on the FMD in 100% of cases was vasoconstriction. In HSV (Group III), 37 (90.2%) patients demonstrated a vasospastic reaction of the BA. In HMO (Group II), vasoconstriction was detected in 23 (12.6%) patients, and 29 (15.9%) patients demonstrated a spastic reaction. In HQM (Group I), 27 (10.3%) patients were detected with vasoconstriction, while in 31 patients (11.83%) a BA spastic reaction was recorded. Conclusions. Endothelium-dependent vasodilation determined by FMD is a practical and affordable method for the detection of endothelial dysfunction in post-COVID-19 patients and allows identification of patients with a higher risk of cardiovascular complications.
- 30 May 2025
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 5,p. 6-12
Open AccessDIAGNOSIS OF POST COVID-19 DISORDERS IN THE FUNCTION OF THE ENDOTHELIUM
Introduction. One of the characteristics of COVID-19, caused by the SARS-CoV-2 virus, is the broad, nonspecific nature of the pathological processes that develop in almost all organs and organ systems of the human body. At the same time, the development of endothelial dysfunction has been identified by many investigators as the pathological process that integrates these disorders and is considered the primary pathophysiological mechanism in severe cases. Aim. Post-COVID-19 infection survivors in 2021–2022 (n = 502) underwent a Flow-Mediated Dilation (FMD) test of upper arm occlusion by the brachial artery. Materials and methods. In the non-invasive study, endothelial dysfunction (ED) was induced with a pneumatic cuff, thereby inflicting compression only on the distal circulation with reactive hyperemia. Manifestation of ED was evaluated by the diameter of the brachial artery (BA) being less than 10% compared to the baseline, or vasoconstriction. Results. The patients were divided into four groups by the severity of the disease. Group I (n = 262) comprised home-quarantined patients with mild symptoms (HQM); Group II (n = 183), patients hospitalized with moderate symptoms (HMO); Group III (n = 41), patients hospitalized with severe symptoms who required oxygen therapy (HSV); and Group IV (n = 16), patients in the Intensive Care Unit (ICU) hospitalized with critical symptoms (HCR). In HCR (Group IV), the reaction of the BA diameter on the FMD in 100% of cases was vasoconstriction. In HSV (Group III), 37 (90.2%) patients demonstrated a vasospastic reaction of the BA. In HMO (Group II), vasoconstriction was detected in 23 (12.6%) patients, and 29 (15.9%) patients demonstrated a spastic reaction. In HQM (Group I), 27 (10.3%) patients were detected with vasoconstriction, while in 31 patients (11.83%) a BA spastic reaction was recorded. Conclusions. Endothelium-dependent vasodilation determined by FMD is a practical and affordable method for the detection of endothelial dysfunction in post-COVID-19 patients and allows identification of patients with a higher risk of cardiovascular complications.
- Open Access
- 31 July 2020
- Published by Pensoft Publishers in Pharmacia
- Vol. 67 (2) , 63-69
HPLC MS/MS method development for the quantitative determination of verapamil hydrochloride from Caco-2 cell monolayers
Aim. An understanding of the role that transporters, in particular P-glycoprotein (P-gp), can play in the absorption, distribution, metabolism and excretion (ADME) of candidate drugs, and an assessment of how these processes might impact on toxicity and the potential for drug-drug interactions in the clinic, is required to support drug development and registration. It is therefore necessary to validate preclinical assays for the in vitro evaluation of candidate drugs as substrates or inhibitors of human P-gp. 2. A simple, rapid HPLC MS/MS method was developed for determination of verapamil hydrochloride from confluent Caco-2 monolayers and from aqueous solution. Materials and methods. Chromatography was achieved on Discovery C18, 50 × 2.1 mm, 5 μm column. Samples were chromatographed in a gradient mode (eluent A (acetonitrile – water – formic acid, 5 : 95 : 0.1 v/v), eluent B (acetonitrile – formic acid, 100 : 0.1 v/v)). The initial content of the eluent B is 0%, which increases linearly by 1.0 min to 100% and to 1.01 min returns to the initial 0%. The mobile phase was delivered at a flow rate of 0.4 mL/min into the mass spectrometer ESI chamber. The sample volume was 5 μl. Results. Under these conditions, verapamil hydrochloride was eluted at 1.08 min. A linear response function was established at 1 – 100 ng/mL. The regression equation for the analysis was Y = 0.0162x + 0.00391 with coefficient of correction (R2) = 0.9992. According to the Caco-2 test results, verapamil showed low permeability. It should be noted that the recovery value for verapamil hydrochloride is 102.69%. The within-run coefficients of variation ranged between 0.336% and 0.617% for verapamil. The within-run percentages of nominal concentrations ranged between 98.82% and 100.62% for verapamil. The between-run coefficients of variation ranged between 0.334% and 0.612% for verapamil. The between-run percentages of nominal concentrations ranged between 98.97% and 101.76% for verapamil. The assay values on both the occasions (intra- and inter-day) were found to be within the accepted limits. Conclusion. From results of analysis, it can be concluded that developed method is simple and rapid for determination of verapamil hydrochloride from confluent Caco-2 monolayers and from aqueous solution. Acquired results demonstrate that proposed strategy can be effortlessly and advantageously applied for examination of verapamil hydrochloride from Caco-2 cell monolayers.
- 31 July 2020
- Published by Pensoft Publishers in Pharmacia
- Vol. 67 (2) , 63-69
Open AccessHPLC MS/MS method development for the quantitative determination of verapamil hydrochloride from Caco-2 cell monolayers
Aim. An understanding of the role that transporters, in particular P-glycoprotein (P-gp), can play in the absorption, distribution, metabolism and excretion (ADME) of candidate drugs, and an assessment of how these processes might impact on toxicity and the potential for drug-drug interactions in the clinic, is required to support drug development and registration. It is therefore necessary to validate preclinical assays for the in vitro evaluation of candidate drugs as substrates or inhibitors of human P-gp. 2. A simple, rapid HPLC MS/MS method was developed for determination of verapamil hydrochloride from confluent Caco-2 monolayers and from aqueous solution. Materials and methods. Chromatography was achieved on Discovery C18, 50 × 2.1 mm, 5 μm column. Samples were chromatographed in a gradient mode (eluent A (acetonitrile – water – formic acid, 5 : 95 : 0.1 v/v), eluent B (acetonitrile – formic acid, 100 : 0.1 v/v)). The initial content of the eluent B is 0%, which increases linearly by 1.0 min to 100% and to 1.01 min returns to the initial 0%. The mobile phase was delivered at a flow rate of 0.4 mL/min into the mass spectrometer ESI chamber. The sample volume was 5 μl. Results. Under these conditions, verapamil hydrochloride was eluted at 1.08 min. A linear response function was established at 1 – 100 ng/mL. The regression equation for the analysis was Y = 0.0162x + 0.00391 with coefficient of correction (R2) = 0.9992. According to the Caco-2 test results, verapamil showed low permeability. It should be noted that the recovery value for verapamil hydrochloride is 102.69%. The within-run coefficients of variation ranged between 0.336% and 0.617% for verapamil. The within-run percentages of nominal concentrations ranged between 98.82% and 100.62% for verapamil. The between-run coefficients of variation ranged between 0.334% and 0.612% for verapamil. The between-run percentages of nominal concentrations ranged between 98.97% and 101.76% for verapamil. The assay values on both the occasions (intra- and inter-day) were found to be within the accepted limits. Conclusion. From results of analysis, it can be concluded that developed method is simple and rapid for determination of verapamil hydrochloride from confluent Caco-2 monolayers and from aqueous solution. Acquired results demonstrate that proposed strategy can be effortlessly and advantageously applied for examination of verapamil hydrochloride from Caco-2 cell monolayers.
- Open Access
- 4 January 2019
- Published by Ternopil State Medical University in Шпитальна хірургія. Журнал імені Л. Я. Ковальчука
- No. 4,p. 95-100
Клініко-лабораторна характеристика хворих на облітеруючий атеросклероз артерій нижніх кінцівок при IIIA-Б – IV ступені хронічної артеріальної недостатності і ризику розвитку реперфузійно-реоксигенаційного синдрому
Мета роботи: Вивчити клініко-лабораторну характеристику хворих на облітеруючий атеросклероз магістральних артерій при ХАН ІІІА-Б – ІV ст. із метою розпрацювання системи профілактики та лікування розвитку реперфузійно-реоксигенаційного синдрому. Матеріали і методи. В основу роботи покладено аналіз комплексного обстеження та хірургічного лікування 119 хворих на облітеруючий атеросклероз аорти та магістральних артерій нижніх кінцівок. Виділено дві групи пацієнтів. Перша група налічувала 63 особи із атеросклеротичним ураженням аорти та магістральних артерій, ХАН ІІІА-Б – ІV ст., друга група налічувала 56 осіб із атеросклеротичним ураженням магістральних артерій, ХАН ІІІА-Б – ІV ст., у яких запідозрено можливий розвиток реперфузійно-реоксигенаційного синдрому після реваскуляризації магістральних артерій нижніх кінцівок. Результати досліджень та їх обговорення. Хворі з другої групи дослідження характеризуються тривалим і високим ступенем хронічної артеріальної недостатності, вираженою неспроможністю колатеральної системи нижньої кінцівки, високим рівнем запальної відповіді, вираженим лейкоцитарним індексом інтоксикації, індексом зсуву лейкоцитів, високою фагоцитарною активністю нейтрофілів, моноцитів та їх оксидативною здатністю, активністю всіх груп цитокінів, підвищеною активністю неспецифічних протеїназ та їх інгібіторів, підвищеною активністю компонентів прооксидантно-антиоксидантної системи, яка не тільки активує вільнорадикальні механізми, але й потенціює процеси ушкодження тканин, вираженою наростаючою ендотеліальною дисфункцією.
- 4 January 2019
- Published by Ternopil State Medical University in Шпитальна хірургія. Журнал імені Л. Я. Ковальчука
- No. 4,p. 95-100
Open AccessКлініко-лабораторна характеристика хворих на облітеруючий атеросклероз артерій нижніх кінцівок при IIIA-Б – IV ступені хронічної артеріальної недостатності і ризику розвитку реперфузійно-реоксигенаційного синдрому
Мета роботи: Вивчити клініко-лабораторну характеристику хворих на облітеруючий атеросклероз магістральних артерій при ХАН ІІІА-Б – ІV ст. із метою розпрацювання системи профілактики та лікування розвитку реперфузійно-реоксигенаційного синдрому. Матеріали і методи. В основу роботи покладено аналіз комплексного обстеження та хірургічного лікування 119 хворих на облітеруючий атеросклероз аорти та магістральних артерій нижніх кінцівок. Виділено дві групи пацієнтів. Перша група налічувала 63 особи із атеросклеротичним ураженням аорти та магістральних артерій, ХАН ІІІА-Б – ІV ст., друга група налічувала 56 осіб із атеросклеротичним ураженням магістральних артерій, ХАН ІІІА-Б – ІV ст., у яких запідозрено можливий розвиток реперфузійно-реоксигенаційного синдрому після реваскуляризації магістральних артерій нижніх кінцівок. Результати досліджень та їх обговорення. Хворі з другої групи дослідження характеризуються тривалим і високим ступенем хронічної артеріальної недостатності, вираженою неспроможністю колатеральної системи нижньої кінцівки, високим рівнем запальної відповіді, вираженим лейкоцитарним індексом інтоксикації, індексом зсуву лейкоцитів, високою фагоцитарною активністю нейтрофілів, моноцитів та їх оксидативною здатністю, активністю всіх груп цитокінів, підвищеною активністю неспецифічних протеїназ та їх інгібіторів, підвищеною активністю компонентів прооксидантно-антиоксидантної системи, яка не тільки активує вільнорадикальні механізми, але й потенціює процеси ушкодження тканин, вираженою наростаючою ендотеліальною дисфункцією.